Evidence map›Paper›PMID 34160650›Full record

ArticleAnnals of hematology2021

Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.

Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, Gesine Bug, Martina Crysandt, Sabine Dressler, Andreas Hausmann, Daniela Heidenreich, Klaus Hirschbühl, Matthias Hoepting and 16 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Esther SchulerDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany. Esther.schuler@med.uni-duesseldorf.de.ORCID https://orcid.org/0000-0001-7182-6502
Eva-Maria Wagner-DrouetDepartment of Hematology, Oncology, Pneumology, Medical Clinic III, UCT Johannes Gutenberg-University Mainz, Mainz, Germany.
Salem AjibDepartment of Medicine II, Goethe University, Frankfurt am Main, Germany.
Gesine BugDepartment of Medicine II, Goethe University, Frankfurt am Main, Germany.
Martina CrysandtDepartment of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany.
Sabine DresslerBone Marrow Transplantation Unit, Medical Clinic 5, Nürnberg, Germany.
Andreas HausmannDepartment of Hematology, Oncology, Immunology, Palliative Care, Munich Clinic Schwabing, Munich, Germany.
Daniela HeidenreichMedical Clinic III, University Medicine Mannheim, Mannheim, Germany.
Klaus HirschbühlDepartment of Hematology and Oncology, Medical Clinic II, University Hospital Augsburg, Augsburg, Germany.
Matthias HoeptingMedical Clinic III, University Medicine Regensburg, Regensburg, Germany.
Edgar JostDepartment of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany.
Jennifer KaiversDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Stefan KleinMedical Clinic III, University Medicine Mannheim, Mannheim, Germany.
Michael KoldehoffClinic for Bone Marrow Transplantation, University Hospital Essen, Essen, Germany.
Lambros KordelasClinic for Bone Marrow Transplantation, University Hospital Essen, Essen, Germany.
Oliver KriegeDepartment of Hematology, Oncology, Pneumology, Medical Clinic III, UCT Johannes Gutenberg-University Mainz, Mainz, Germany.
Lutz P MüllerDepartment of Internal Medicine IV, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Christina RautenbergDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Judith SchaffrathDepartment of Internal Medicine IV, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Christoph SchmidDepartment of Hematology and Oncology, Medical Clinic II, University Hospital Augsburg, Augsburg, Germany.
Daniel WolffMedical Clinic III, University Medicine Regensburg, Regensburg, Germany.
Rainer HaasDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Martin BornhäuserDepartment of Internal Medicine I, University Hospital Carl Gustav Carus at the Technische Universität, Dresden, Germany.
Thomas SchroederDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Guido KobbeDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
German Cooperative Transplant Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34160650
PMCPMC8587257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.